Log in with your email address username.


Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

Do teleoncology models of care enable safe delivery of chemotherapy in rural towns?

- Featured Image

Even in developed nations, cancer survival rates among patients from rural regions are often inferior to those of their urban counterparts.13 In Australia, these problems are further compounded by the poorer outcomes for Indigenous patients compared with non-Indigenous patients.4 Reasons that have been proposed to explain this disparity include the differential access of rural and urban patients to various cancer screening and treatment programs.5 Achieving timely and equitable access to cancer care services for all patients remains a significant challenge, especially in large countries with geographically dispersed populations, such as Australia.

When compared with their urban counterparts, rural patients in New South Wales have different rates of prostatectomy and orchiectomy for prostate cancer,6 undergo less breast-conserving surgery for breast cancer,7 and have a lower probability of completing radiotherapy for rectal cancer.8 Overseas studies have also reported that the uptake of chemotherapy may be lower for patients from rural areas; for example, patients with colorectal cancer living in disadvantaged areas of Scotland were less likely to receive chemotherapy.9